Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

INdependence Through Endovascular Neuroprosthetic Technology (INTENT): an Early Feasibility Study

NCT07543367 is registered in ClinicalTrials.gov with Synchron, Inc. as lead sponsor.

NCT NCT07543367
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07543367 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
INdependence Through Endovascular Neuroprosthetic Technology (INTENT): an Early Feasibility Study
Lead sponsor
Synchron, Inc.
Phase
Not applicable
Overall status
Recruiting
Start date
April 30, 2026
Completion date
December 31, 2029
Enrollment
10 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

als, als (amyotrophic lateral sclerosis), als - amyotrophic lateral sclerosis, motor neuron disease, neurological disorder